Sanofi has announced it will be working on a coronavirus vaccine with its competitor Glaxoklinesmith, but has also reported its concerns about the capacity to produce enough vaccine in the future. Yahoo Finance’s Anjalee Khemlani joins The Final Round panel to break down the latest news about the coronavirus. ...
While companies have scrambled to keep the U.S. supply chain running amid the novel coronavirus pandemic, the pressure is mounting for the pork industry. ...
(Bloomberg) -- Revlon Inc. increased the size of a $1.8 billion plan to rework its debt in an effort to increase liquidity and ride out the pandemic, according to people with knowledge of the situation.The cosmetics company tacked on $30 million to a senior secured term loan in its refinancing package to make it $880 million total, the people said, asking not to be identified discussing a private matter. Revlon also signed a new revolving credit facility of about $100 million with certain lenders, the people said. Both provide the company with further support to ride out the loss of sales caused by the coronavirus outbreak.Revlon will also continue talks with debt holders beyond a now-expired April 23 deadline for the offer, said the people. A representative for the New York-based company declined to comment.The refinancing plan is the latest from billionaire Ronald Perelman’s cosmetics empire to ease its debt load...
(Bloomberg) -- At the end of the calmest week in two months for the S&P 500, it has gotten a little easier to see how stock bulls are thinking about the market’s valuation. More than ever it involves looking past this year.Perched around 2,800, the benchmark trades for 21 times analysts’ best guess for 2020 earnings, a multiple at the highest end of the historical range. Look a little further out, though, and things settle down. Relative to 2021 forecasts, the forward price-earnings ratio falls to 17, very close to its historical average over the last half century.It’s one of the many peculiarities of the coronavirus era, that faced with a choice between endless uncertainty and the belief a recovery will one day take hold, investors are casting their fate with the latter. While skeptics ask how anyone can write off a year like this one, bulls pin their hopes on...
Shopify (NYSE:SHOP) stock is a wild one. Trading it is not for the faint of heart. If you are waiting for an easy entry point, you are going to be waiting a long time. The speed at which the shares move baffles most investors. Therefore it is much easier to invest in it with a particular thesis then try to trade it, unless you know the charts well.Source: justplay1412 / Shutterstock.com So get ready for a discussion of levels to guide us through the price action.Looking back at the last three days, SHOP stock was as high as $666 and as low as $560 per share. At yesterday's close, it was just above the middle, so clearly investors are undecided about it here.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe traders that are technically savvy have a lot of opportunities to scalp big profits intraday in both directions. Zooming...
